These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18437350)

  • 1. Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I.
    Nobécourt E; Zeng J; Davies MJ; Brown BE; Yadav S; Barter PJ; Rye KA
    Diabetologia; 2008 Jun; 51(6):1008-17. PubMed ID: 18437350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase.
    Nobecourt E; Davies MJ; Brown BE; Curtiss LK; Bonnet DJ; Charlton F; Januszewski AS; Jenkins AJ; Barter PJ; Rye KA
    Diabetologia; 2007 Mar; 50(3):643-53. PubMed ID: 17216278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of spherical, reconstituted high density lipoproteins containing both apolipoproteins A-I and A-II is mediated by lecithin:cholesterol acyltransferase.
    Clay MA; Pyle DH; Rye KA; Barter PJ
    J Biol Chem; 2000 Mar; 275(12):9019-25. PubMed ID: 10722751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of sphingomyelin on the structure and function of reconstituted high density lipoproteins.
    Rye KA; Hime NJ; Barter PJ
    J Biol Chem; 1996 Feb; 271(8):4243-50. PubMed ID: 8626769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase.
    Liang HQ; Rye KA; Barter PJ
    J Lipid Res; 1996 Sep; 37(9):1962-70. PubMed ID: 8895062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.
    Durbin DM; Jonas A
    J Lipid Res; 1999 Dec; 40(12):2293-302. PubMed ID: 10588955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein.
    Settasatian N; Barter PJ; Rye KA
    J Lipid Res; 2008 Jan; 49(1):115-26. PubMed ID: 17921435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of lecithin:cholesterol acyltransferase to reconstituted high density lipoproteins is affected by their lipid but not apolipoprotein composition.
    Bolin DJ; Jonas A
    J Biol Chem; 1994 Mar; 269(10):7429-34. PubMed ID: 8125962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants.
    Jonas A; von Eckardstein A; Kézdy KE; Steinmetz A; Assmann G
    J Lipid Res; 1991 Jan; 32(1):97-106. PubMed ID: 1901346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
    Cho KH; Durbin DM; Jonas A
    J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine decrease the stability of recombinant high density lipoprotein apolipoprotein A-I and the activation energy of the lecithin:cholesterol acyltransferase reaction.
    Parks JS; Gebre AK
    J Lipid Res; 1997 Feb; 38(2):266-75. PubMed ID: 9162746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle.
    Durbin DM; Jonas A
    J Biol Chem; 1997 Dec; 272(50):31333-9. PubMed ID: 9395462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
    Sparks DL; Frank PG; Neville TA
    Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I.
    Nobécourt E; Tabet F; Lambert G; Puranik R; Bao S; Yan L; Davies MJ; Brown BE; Jenkins AJ; Dusting GJ; Bonnet DJ; Curtiss LK; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):766-72. PubMed ID: 20110571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E.
    Rye KA; Bright R; Psaltis M; Barter PJ
    J Lipid Res; 2006 May; 47(5):1025-36. PubMed ID: 16452453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the Arg123-Tyr166 paired helix of apolipoprotein A-I in lecithin:cholesterol acyltransferase activation.
    Dhoest A; Zhao Z; De Geest B; Deridder E; Sillen A; Engelborghs Y; Collen D; Holvoet P
    J Biol Chem; 1997 Jun; 272(25):15967-72. PubMed ID: 9188498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of high density lipoproteins containing both apolipoprotein A-I and A-II in the rabbit.
    Hime NJ; Drew KJ; Wee K; Barter PJ; Rye KA
    J Lipid Res; 2006 Jan; 47(1):115-22. PubMed ID: 16222033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers associated with high-density lipoproteins in atherosclerotic kidney disease.
    Rye KA
    Clin Exp Nephrol; 2014 Apr; 18(2):247-50. PubMed ID: 24052156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties.
    Hoang A; Murphy AJ; Coughlan MT; Thomas MC; Forbes JM; O'Brien R; Cooper ME; Chin-Dusting JP; Sviridov D
    Diabetologia; 2007 Aug; 50(8):1770-9. PubMed ID: 17579831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.